Novel thyroid hormones
- 20 July 2019
- journal article
- review article
- Published by Springer Nature in Endocrine
- Vol. 66 (1) , 95-104
Abstract
The field of thyroid hormone signaling has grown more complex in recent years. In particular, it has been suggested that some thyroid hormone derivatives, tentatively named "novel thyroid hormones" or "active thyroid hormone metabolites", may act as independent chemical messengers. They include 3,5-diiodothyronine (T2), 3-iodothyronamine (T1AM), and several iodothyroacetic acids, i.e., 3,5,3',5'-thyroacetic acid (TA4), 3,5,3'-thyroacetic acid (TA3), and 3-thyroacetic acid (TA1). We summarize the present knowledge on these compounds, namely their biosynthetic pathways, endogenous levels, molecular targets, and the functional effects elicited in experimental preparations or intact animals after exogenous administration. Their physiological and pathophysiological role is discussed, and potential therapeutic applications are outlined. The requirements needed to qualify these substances as chemical messengers must still be validated, although promising evidence has been collected. At present, the best candidate to the role of independent chemical messenger appears to be T1AM, and its most interesting effects concern metabolism and brain function. The responses elicited in experimental animals have suggested potential therapeutic applications. TA3 has an established role in thyroid hormone resistance syndromes, and is under investigation in Allen-Herndon-Dudley syndrome. Other potential targets are represented by obesity and dyslipidemia (for T2 and T1AM); dementia and degenerative brain disease (for T1AM and TA1); cancer (for T1AM and TA4). Another intriguing and unexplored question is the potential relevance of these metabolites in the clinical picture of hypothyroidism and in the response to replacement therapy.Keywords
This publication has 69 references indexed in Scilit:
- Distribution of exogenous [125I]-3-iodothyronamine in mouse in vivo: relationship with trace amine-associated receptorsJournal of Endocrinology, 2012
- Cardioprotective Effect of 3-Iodothyronamine in Perfused Rat Heart Subjected to Ischemia and ReperfusionCardiovascular Drugs and Therapy, 2011
- An online solid-phase extraction–liquid chromatography–tandem mass spectrometry method to study the presence of thyronamines in plasma and tissue and their putative conversion from 13C6-thyroxineJournal of Endocrinology, 2010
- Identification and Characterization of 3-Iodothyronamine Intracellular TransportEndocrinology, 2009
- Thyronamines Are Isozyme-Specific Substrates of DeiodinasesEndocrinology, 2008
- The MCT8 thyroid hormone transporter and Allan–Herndon–Dudley syndromeBest Practice & Research Clinical Endocrinology & Metabolism, 2007
- Uptake of triiodothyronine and triiodothyroacetic acid in neonatal rat cardiomyocytes: effects of metabolites and analogsJournal of Endocrinology, 2002
- Characterization of Cytoplasmic T 3 Binding Sites by Adsorption to Hydroxyapatite: Effects of Drug Inhibitors of T 3 and Relationship to Glutathione-S-TransferasesThyroid®, 1992
- A RADIOIMMUNOASSAY FOR 3,5-DIIODOTHYRONINEClinical Endocrinology, 1978
- Recent Work on Thyroid HormonesPostgraduate Medical Journal, 1957